U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06889636) titled 'Pharmaceutical Care and Quality of Life in Conditions Related to Psychotropic Drug Use' on Feb. 25.
Brief Summary: This study aims to assess and describe the impact of pharmaceutical care on identified drug-related problems (DRPs) in subjects using psycholeptics and psychoanaleptics in primary care, improving subjects' self-assessed quality of life (QoL)
The hypothesis of the study are:
1. Side-effects are the most common DRPs in subjects using psychotropic medicines in primary care,
2. Treatment effectiveness and safety affect the subjects' QoL
Study Start Date: Dec. 01, 2021
Study Type: INTERVENTIONAL
Condition:
Mental Hea...